Miró M. ¿Se acerca el fin de la succinilcolina? Estudio dosis-respuesta de Sugammadex: Reversal of profound, high-dose rocuronium-induced neuromuscular blockade by sugammadex at two different time points: an international, multicenter, randomized, dose-finding, safety assessor-blinded, phase II trial. Pühringer FK, Rex C, Sielenkämper AW, Claudius C, Larsen PB, Prins ME, Eikermann M, Khuenl-Brady KS. Anesthesiology 2008; 109 (2): 188-97. Rev Elect AnestesiaR [Internet]. 31 de octubre de 2009 [citado 6 de mayo de 2024];1(10):1. Disponible en: https://revistaanestesiar.org/index.php/rear/article/view/585